# ImprimisRx NJ – FDA 483, Apr 9, 2019

Source: https://www.keypedia.com/records/483/imprimisrx-nj/d2c04a43-2dd3-4e66-b9f0-b343dd87b27a

> FDA 483 for ImprimisRx NJ on April 09, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ImprimisRx NJ
- Inspection Date: 2019-04-09
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: An FDA inspection of ImprimisRx in Ledgewood, NJ, identified a critical issue with the aseptic processing environment. The ISO 7 Filling Room, used for sterile ophthalmic and injectable drug products, was found to have inadequately constructed ceiling tiles that moved during cleaning, compromising aseptic conditions. This poses a risk to the sterility of manufactured drug products.

## Related Documents

- [483 - 2022-08-05](https://www.keypedia.com/records/483/imprimisrx-nj/e4cc7967-3ab1-43d0-913d-52bbaafb5198) — date: August 5, 2022
- [WARNING_LETTER - 2022-08-05](https://www.keypedia.com/records/warning_letter/imprimisrx-nj/5cc5aba9-596e-4551-9c9b-e341f4d45be9) — date: August 5, 2022
- [UNTITLED_LETTER - 2018-09-25](https://www.keypedia.com/records/untitled_letter/imprimisrx-nj/82fe5c00-c382-4232-a987-d66796b33848) — date: September 25, 2018
- [483 - 2017-07-10](https://www.keypedia.com/records/483/imprimisrx-nj/557994ed-7478-4f2c-a5b6-69cb71603297) — date: July 10, 2017
- [483 - 2015-09-30](https://www.keypedia.com/records/483/imprimisrx-nj/147d9ef0-0246-4a30-b3fa-bf5d11c11ce6) — date: September 30, 2015

## Related Officers

- [investigator](https://www.keypedia.com/people/jay-wong/d58065c6-6c52-4d77-af6b-089176c778c9)
- [CSO](https://www.keypedia.com/people/nancy-f-scheraga/7ab7500d-901f-4953-95a7-4a2b22488f04)

Company: https://www.keypedia.com/companies/imprimisrx-nj/4c5c7886-bcf6-4aa1-aa74-882590c33746

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
